The autonomous security system developer, which is backed by NTT Docomo, Konica Minolta and Flextronics, has closed the first half of a mini-IPO.

Iheima has raised $27.3m in its initial public offering, becoming the first incubator to float in China and providing an exit to corporate investors Toread and Youyou.

UCB Pharma scored an exit after the bone disease therapy developer floated at the top of its range, having secured $92.5m in funding over the past two years.

Dermatology product developer and JLabs graduate Sienna Biopharmaceuticals floated at the middle of its range having raised $86m in venture funding.

The Rocket Internet-owned Global Online Takeaway Group sold some $148m in shares, as the online food ordering platform floated at the top of its range.

The cancer drug conjugate developer floated in the middle of its range, in an offering that provided exits to Takeda subsidiary Millennium Pharmaceuticals and Pfizer.

The gunfire detection technology provider floated in the middle of its range in a $30.8m IPO that gave an exit to Motorola Solutions Venture Capital.

Cancer therapy developer G1 Therapeutics has gone public in an initial public offering that gave an exit to long-time investor MedImmune Ventures.

The neurological disorder drug developer has floated in an initial public offering that gave pharmaceutical companies Sanofi and Takeda exits.